Risk assessment in haematopoietic stem cell transplantation

Best Pract Res Clin Haematol. 2007 Jun;20(2):119-24. doi: 10.1016/j.beha.2006.10.011.

Author

Alois Gratwohl¹

Affiliation

¹ Haematology, Department of Medicine, University Hospital Basel, CH-4031 Basel, Switzerland. hematology@uhbs.ch

PMID: 17448952
DOI: 10.1016/j.beha.2006.10.011

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Acute Disease
Adult
Female
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
Leukemia, Myeloid / therapy
Male
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
Risk Assessment
Treatment Outcome